Jiangxi Fushine Pharmaceutical Co (SZSE:300497) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co Change In Payables And Accrued Expense?

Jiangxi Fushine Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Jiangxi Fushine Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Jiangxi Fushine Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Jiangxi Fushine Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Jiangxi Fushine Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Jiangxi Fushine Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Fushine Pharmaceutical Co Change In Payables And Accrued Expense Chart

Jiangxi Fushine Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Jiangxi Fushine Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Jiangxi Fushine Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Jiangxi Fushine Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Jiangxi Fushine Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Fushine Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000

Website

http://www.fushine.cn

Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.

Executives

Liu Ying	Executives
Peng Yun	Secretary Dong
Zhang Xiang Ming	Executives
Wei Hai Peng	Executives
Bao Jian Hua	Directors, executives
Li Hui Yue	Director
Dai Zhen Liang	Executives
Yang Guang	Executives
Chen Ying Hui	Executives
Ke Dan	Director
Xu Chun Xia	Directors, executives
Yu Wen Jun	Director
Cheng Rong Wu	Directors, executives
Liu Zhi Min	Executives
Tang De Ping	Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines